Veeva Systems and the Sarah Cannon Research Institute (SCRI) announced a strategic collaboration to accelerate and improve the efficiency of oncology clinical trials across more than 200 SCRI research sites. SCRI is adopting Veeva Clinical Platform to unify its contract research organization (CRO) and site management organization (SMO) on a single platform for seamless data flow between clinical teams and research sites.
“We are excited to advance our clinical trials by integrating Veeva Clinical Platform into our digital toolbox,” said Yazhene Krishnaraj, Chief Information and Digital Officer at SCRI. “This strategic collaboration enables our clinical teams to bring innovative treatments to patients with greater accuracy and speed.”
Veeva Clinical Platform will enable SCRI to simplify and standardize trial processes and information flow, improving how researchers and clinical teams collaborate and share data. With a connected foundation for clinical research, SCRI will be able to automate essential processes and deliver a streamlined experience to its sites.
Also Read: Investment to Fuel Growth in Cell and Gene Therapy
“We are excited to work closely with SCRI to drive innovation in oncology research,” said Jim Reilly , president of Veeva Development Cloud. “In a unique partnership, Veeva Clinical Platform will serve as the foundation for SCRI’s clinical trials for its CRO and SMO. By standardizing operations on a single platform, we can help SCRI run trials faster and more cost-effectively.”
SOURCE: PRNewswire